Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03718403
PHASE4
Effect of Theophylline in Pseudohypoparathyroidism
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
The study evaluates the effect of theophylline in 100 subjects with Pseudohypoparathyroidism.
Key Details
Gender
All
Age Range
5 Years - 21 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2019-11-11
Completion Date
2032-04-10
Last Updated
2022-07-22
Healthy Volunteers
No
Interventions
DRUG
Theophylline
Theophylline will be given to maintain a peak level between 10-15 mcg/mL
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States